FDMT
NASDAQ Healthcare4D Molecular Therapeutics, Inc. - Common Stock
Biotechnology
4D Molecular Therapeutics, Inc., a late-stage biotechnology company, engages in the development of adeno-associated virus vectors from its proprietary synthetic vector discovery platform, Therapeutic Vector Evolution in the Netherlands and the United States. The company's lead product candidate is 4D-150 for the treatment of retinal vascular diseases by providing multi-year sustained production of anti-VEGF from the retina with intravitreal injection, as well as for treating wet age-related macular degeneration and diabetic macular edema. It is also developing 4D-710, which is in early-stage study for the treatment of cystic fibrosis; 4D-175 that is in preclinical stage for treating geographic atrophy; and 4D-725, which is in preclinical stage for the treatment of alpha-1 anti-trypsin deficiency lung disease. 4D Molecular Therapeutics, Inc. has collaboration and licensing agreements with Otsuka Pharmaceutical Co., Ltd. The company was founded in 2013 and is headquartered in EmeryVille, California.
๐ Market Data
| Price | $9.09 |
|---|---|
| Volume | 785,399 |
| Market Cap | 475.18M |
| Beta | 2.930 |
| RSI (14-Day) | 35.8 |
| 200-Day MA | $8.65 |
| 50-Day MA | $9.35 |
| 52-Week High | $12.34 |
| 52-Week Low | $3.00 |
| Forward P/E | -2.36 |
| Price / Book | 1.04 |
๐ฏ Investment Strategy Scores
FDMT scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Moon Shot (98/100) โ this strategy High growth potential (high beta + oversold).
Lowest fit among scored strategies: ๐ฐ Dividend Daddy (1/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find FDMT in your text
Paste any article, transcript, or post โ the tool will extract FDMT and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.